Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,285,616
+$479,611 QoQ
Shares Held
243,028
+13.1% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 149 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. ACRS ranks #138 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ACRS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,285,616 | 243,028 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $806,005 | 214,935 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $631,807 | 209,903 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $308,678 | 162,463 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $192,166 | 135,329 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $87,330 | 57,079 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $27,813 | 11,215 | Shares | Defined | 2025-02-13 | |
| 2024-03-31 | $37,816 | 30,498 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $33,239 | 31,657 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $272,066 | 39,718 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $420,699 | 40,569 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $308,527 | 38,137 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $437,581 | 27,783 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $456,223 | 28,985 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $345,775 | 24,769 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $415,069 | 24,076 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $353,888 | 24,339 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,898,436 | 438,802 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $349,724 | 19,916 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $22,857,256 | 907,034 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $604,763 | 93,472 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $250,616 | 97,516 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $163,198 | 100,740 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $119,347 | 114,757 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||